hua xiao
Michigan State University
East Lansing, United States
Review Editor
Cancer Molecular Targets and Therapeutics
Michigan State University
East Lansing, United States
Review Editor
Cancer Molecular Targets and Therapeutics
Zhejiang University
Hangzhou, China
Review Editor
Cancer Molecular Targets and Therapeutics
Key Laboratory of Tumor Molecular Biology, Binzhou Medical University
Yantai, China
Review Editor
Cancer Molecular Targets and Therapeutics
Houston Methodist Research Institute
Houston, United States
Review Editor
Cancer Molecular Targets and Therapeutics
Northwestern University
Evanston, United States
Review Editor
Cancer Molecular Targets and Therapeutics
Clinical Research Centre, Faculty of Medicine, Lund University
Malmo, Sweden
Review Editor
Cancer Molecular Targets and Therapeutics
Shanghai Sixth People's Hospital, Shanghai Jiao Tong University
Shanghai, China
Review Editor
Cancer Molecular Targets and Therapeutics
Tianjin Medical University Cancer Institute and Hospital
Tianjin, China
Review Editor
Cancer Molecular Targets and Therapeutics
City of Hope National Medical Center
Duarte, United States
Review Editor
Cancer Molecular Targets and Therapeutics
Stony Brook University
Stony Brook, United States
Review Editor
Cancer Molecular Targets and Therapeutics
City of Hope National Medical Center
Duarte, United States
Review Editor
Cancer Molecular Targets and Therapeutics
University of North Carolina at Chapel Hill
Chapel Hill, United States
Review Editor
Cancer Molecular Targets and Therapeutics
Lewis Katz School of Medicine, Temple University
Philadelphia, United States
Review Editor
Cancer Molecular Targets and Therapeutics
National Institutes of Health (NIH)
Bethesda, United States
Review Editor
Cancer Molecular Targets and Therapeutics
Massachusetts General Hospital, Harvard Medical School
Boston, United States
Review Editor
Cancer Molecular Targets and Therapeutics
Nanyang Technological University
Singapore, Singapore
Review Editor
Cancer Molecular Targets and Therapeutics